Sionna Therapeutics is trading at $3.51, up 7.49%, with broad market gains likely supporting the move. - The S&P 500, Nasdaq, and Dow each gained more than 1.5%. - No company-specific catalyst has been confirmed for the November 9 move. - Sionna Therapeutics was scheduled to participate in a Guggenheim healthcare conference at 10:30 a.m. ET, announced November 2. The scheduled investor event is not evidence of a new company announcement.